این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Research in Medical Sciences، جلد ۲۷، شماره ۲۰، صفحات ۲۰۲۲-۲۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی The impact of underlying diseases-related drugs on the chronic kidney disease-associated pruritus in hemodialysis patients
چکیده انگلیسی مقاله Background: Uremic pruritus or chronic kidney disease?associated pruritus (CKD?aP) is a frequent compromising symptom in end?stage renal disease. Despite the little attention paid to drugs used among hemodialysis (HD) patients, investigating medications used in this population of patients and examining the status of CKD?aP may lead to the identification of medications that improve or worsen the pruritus condition. We aimed to assess the role of underlying diseases?related drugs on CKD?aP in HD patients. Materials and Methods: We performed a case ? control study on HD patients aged over 18 years old. The emographic data and clinical parameters including HD parameters, drug history, dermatologic assessments, and laboratory examination were assessed. Results: We compared 128 patients with CKD?aP as cases and 109 patients without CKD?aP as controls. Cases were on the longer course of dialysis (44.69 ± 43.24 months for cases vs. 38.87 ± 50.73 months for controls; P = 0.02). In multiple analyses of variables related to CKD?aP, backward LR logistic regression revealed that only torvastatin (P = 0.036) was considered to be a predictive factor associated with KD?aP. Thus, the use of atorvastatin reduced the index of CKD?aP (95% confidence interval: 0.256–0.954, odd’s Ratio = 0.494). Conclusion: Atorvastatin was associated with decreased frequencies of CKD?aP among HD patients in our study. This knowledge may guide further clinical trials to evaluate atorvastatin’s immunomodulatory and nti?inflammatory effects on the CKD?aP in HD populations. Key words: Amiodarone, atorvastatin, chronic kidney disease, hemodialysis, pruritus, valsartan Address for correspondence: Dr. Narges Alizadeh, Department of Dermatology, Skin Research Center, Razi ospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. E?mail: narges.alizadeh7@gmail.com Submitted: 20?Jul?2021; Revised: 05?Mar?2022; Accepted: 20?Jun?2022; Published: 25-Nov-2022 Access this article online Quick Response Code: Website: www.jmsjournal.net DOI: 10.4103/jrms.jrms_633_21 How to cite this article: Azimi SZ, Alizadeh N, Ramezanzadeh E, Monfared A, Leili EK. The impact of underlying diseases
کلیدواژه‌های انگلیسی مقاله Amiodarone, atorvastatin, chronic kidney disease, hemodialysis, pruritus, valsartan
نویسندگان مقاله | Seyyede Zeinab Azimi


| Narges Alizadeh


| Elham Ramezanzadeh


| Ali Monfared


| Ehsan Kazemnejad Leili


نشانی اینترنتی http://jrms.mui.ac.ir/index.php/jrms/article/view/11393
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات